The PPAR-γ/SFRP5/Wnt/β-catenin signal axis regulates the dexamethasone-induced osteoporosis

Hai-Peng He1, Shan Gu1

  • 1Shenzhen Institute of ENT & Longgang ENT Hospital, Shenzhen 518172, China.

Cytokine
|April 5, 2021
PubMed
Abstract

Insights

Glucocorticoids (GC) inhibit bone formation by affecting osteoblastic differentiation. This study shows that peroxisome proliferator-activated receptor-gamma (PPAR-γ) plays a key role in this process, impacting the Wnt/β-catenin pathway.

Area of Science:

  • Cell Biology
  • Stem Cell Research
  • Endocrinology

Background:

  • Glucocorticoids (GC) inhibit bone formation by suppressing osteoblastic differentiation of bone marrow stromal stem cells (BMSC).
  • Peroxisome proliferator-activated receptor-gamma (PPAR-γ) has been implicated in GC-mediated cellular processes.
  • The precise role of PPAR-γ in GC-induced inhibition of osteoblastogenesis remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of PPAR-γ in regulating osteoblastic differentiation of rat bone marrow stromal stem cells (rBMSC) under glucocorticoid treatment.
  • To explore the molecular mechanisms underlying PPAR-γ's influence on GC-induced suppression of osteogenesis.

Main Methods:

  • Established an in vitro model of GC-induced osteoporosis using dexamethasone (Dex)-treated rBMSC.
  • Quantified the expression of PPAR-γ, RUNX2, ALP, OPN, and SFRP5 using RT-qPCR and Western blot.
  • Assessed osteogenic differentiation via Alizarin Red S staining and manipulated PPAR-γ and SFRP5 levels using lentiviral vectors.

Main Results:

  • Dexamethasone significantly inhibited rBMSC osteoblastic differentiation and increased PPAR-γ expression.
  • Downregulation of PPAR-γ ameliorated the inhibitory effects of Dex on osteogenesis and promoted key osteogenic markers.
  • PPAR-γ knockdown led to decreased SFRP5 and increased Wnt/β-catenin signaling, which was reversed by SFRP5 overexpression.

Conclusions:

  • PPAR-γ plays a critical role in mediating the inhibitory effects of glucocorticoids on osteoblastic differentiation.
  • The PPAR-γ/SFRP5 axis regulates osteogenic differentiation through the Wnt/β-catenin signaling pathway in the context of GC-induced osteoporosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K